Vivalytic PCR rapid test for the detection of Bordetella infection.

Reliable test results with the Vivalytic C. auris test*

Candida auris is an emerging fungal pathogen of the genus Candida, which is becoming increasingly important worldwide as a cause of serious nosocomial infections. The often occurring multiple resistances to antimycotics poses serious therapeutic challenges. Regarding limited therapeutic options and the potential severity of the infections, the containment of outbreaks and control of transmission of Candida auris in healthcare settings requires strict adherence to hygiene measures, the development and use of effective antifungal therapies and precise diagnostics.(1),(2)

Candida auris is a commensal inhabitant that colonizes various parts of the human body, such as the skin, ears and wounds. Once entering the bloodstream Candida auris can cause bloodstream-associated infections. The pathogen shows a broad range of symptoms like sepsis, urinary tract infections, wound infections, ear infections and respiratory tract infections. Many people carry the fungus without showing symptoms, therefore unrecognized transmission can occur. However, people with severe underlying medical conditions or a compromised immune system are at increased risk of Candida auris infections.(1),(3)

Candida auris is transmitted from person to person or via surfaces, especially in healthcare facilities, where uncontrolled transmission can lead to outbreaks.(2),(4)

The point-of-care PCR test* from Vivalytic enables rapid and targeted detection of Candida auris directly at the point of sample collection. Compared to the time-consuming traditional diagnostic methods, the Vivalytic C. auris test offers an ideal opportunity to speed up detection and outbreak containment.

Pathogens detectable with Vivalytic C. auris

Candida auris (ITS2 gene)

Vivalytic C. auris- Fast laboratory testing for outbreak containment

Sensitive screening test to contain outbreaks and limit transmission of Candida auris in hospital environments
Only a few steps from sample to result
No further laboratory equipment needed

(1) Centers for Disease Control and Prevention. Candida auris. 2023 https://www.cdc.gov/fungal/candida-auris/candida-auris-qanda.html. Abgerufen am 14.11.2023.

(2) Aldejohann AM, Wiese-Posselt M, Gastmeier P, Kurzai O., Expert recommendations for prevention and management of Candida auris transmission. Mycoses. 2022;65:590–598. doi:10.1111/myc.13445

(3) Centers for Disease Control and Prevention. Candida auris. 2023 https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html. Abgerufen am 14.11.2023.

(4) Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned; YanChun Zhu et al.; J Clin Microbiol. 2020 Apr; 58(4): e01503-19. Published online 2020 Mar 25. Prepublished online 2019 Dec 18. doi: 10.1128/JCM.01503-19;.

*Currently under development. Available as Research Use Only (RUO). Not for use in diagnostic procedures.

The advantages at a glance

Vivalytic stands for high efficiency and safety with minimum effort. The unique Vivalytic platform provides ideal assistance for everyday work in clinics, practices, and laboratories.

Comprehensive results

By using a single cartridge, the Vivalytic C. auris test enables rapid screening of the patient for Candida auris.

High usability

The minimalistic design, easy handling and comprehensive depiction of the results ensure a high level of usability.

Easy handling

Like all Vivalytic tests, the Vivalytic C. auris test is fully automated. This allows for fewer work steps, saving valuable time.

Find a distribution partner now & use Vivalytic for testing

View distribution partners

Only few steps from sample to result

A woman in a white coat is performing a test on the Vivalytic Analyser in a laboratory. She is in the process of scanning the sample code. The picture contains a white box, in which you can read the text "1. Scan the sample code."

A woman in a white coat is standing in front of a Vivalytic Analyser and is scanning a cartridge. The picture contains a white box, in which you can read the text "2. Scan the cartridge code."

A hand in a hygienic glove that is placing sample material from a pipette into a Vivalytic cartridge. A Vivalytic Analyser is on the table next to the cartridge. The picture contains a white box, in which you can read the text "3. Fill in the sample and close the cartridge cover."

A cartridge is being inserted into a Vivalytic Analyser. There is a white box, in which you can read the text "4. Insert the cartridge – the test will start automatically."

What exactly happens in the Vivalytic Analyser?

The Vivalytic Analyser automates complex, molecular diagnostic processes that previously had to be carried out manually. This promotes high safety and quick availability of the test results.

1. Step	2. Step	3. Step	4. Step	5. Step
1. Step Preparing the sample	2. Step Cell lysis	3. Step Extraction of the nucleic acid	4. Step DNA amplification	5. Step Bio-analytical detection
1. Step	2. Step	3. Step	4. Step	5. Step
1. Step Samples are processed reliably.	2. Step The external membrane of the cells is broken down through ultrasound.	3. Step The nucleic acid (DNA/RNA) is purified for the PCR amplification.	4. Step Specific DNA sequences are multiplied using PCR.	5. Step The amplified DNA is identified by detecting a fluorescence or chemiluminescence signal.

Get the new PCR test with Vivasuite

You can conveniently carry out updates remotely via the digital platform for Vivalytic products. This means that you will always have the latest tests available.

Find out more about Vivasuite

Discover our distribution partners